Bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate


Curated chemical-phenotype interactions from CTD
GO IDGO nameInteraction typeReference
GO:0000084 Mitotic s phase Decreases phenotype PMID:28318508
GO:0000086 G2/m transition of mitotic cell cycle Increases phenotype PMID:28318508
GO:0006629 Lipid metabolic process Affects phenotype PMID:38969211
GO:0006749 Glutathione metabolic process Affects phenotype PMID:34784780
GO:0006915 Apoptotic process Increases phenotype PMID:28318508
GO:0034440 Lipid oxidation Increases phenotype PMID:34784780
GO:0042445 Hormone metabolic process Affects phenotype PMID:23333513
GO:0044237 Cellular metabolic process Decreases phenotype PMID:28318508; PMID:38969211
GO:0045023 G0 to g1 transition Increases phenotype PMID:28318508
GO:0045444 Fat cell differentiation Increases phenotype PMID:28437481
GO:0045930 Negative regulation of mitotic cell cycle Affects phenotype PMID:28318508
GO:0051881 Regulation of mitochondrial membrane potential Affects phenotype PMID:28318508
GO:0140042 Lipid droplet formation Increases phenotype PMID:28437481
GO:2000611 Positive regulation of thyroid hormone generation Increases phenotype PMID:38135142
DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.